(See the full event: Should the Government Insert Itself between Dying Patients and Unproven Therapies?).
When should the terminally ill have access to relatively untested but potentially lifesaving drugs? What has the Supreme Court said about the right of medical treatment? J. Scott Ballenger, a partner with the Latham & Watkins law firm, makes the case for expanded access to experimental drugs among the terminally ill.